FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210133344> ?p ?o ?g. }

• W3210133344 endingPage "S1035" @default.
• W3210133344 startingPage "S1035" @default.
• W3210133344 abstract "Introduction: Crohn’s disease (CD) has many associated skin disorders. Metastatic Crohn’s disease (MCD) is one such disorder, defined by non-suppurative sarcoidal granulomas that are noncontiguous with the gastrointestinal tract. Owing to the rarity of MCD, there is no clinical trial data or consensus to guide treatment. Ustekinumab (UST) is a novel potential treatment for MCD with few reports to support its use. Here we present a patient with biopsy-proven MCD that improved after UST treatment. Case description/methods: The patient is a 37-year-old woman with a history of perianal- and internal-penetrating ileocolonic CD. She had secondary loss of response to infliximab and primary non-response to adalimumab and certolizumab pegol. After several years of management with steroids and azathioprine she presented with worsening perineal, gluteal, and bilateral inframammary ulcerations. Biopsies of the ulcer borders showed granulomatous inflammation. After further workup, she was diagnosed with MCD and treated with steroids and a loading dose of UST. She was lost to follow-up but returned to our institution 5 months later with worsening MCD after tapering off prednisone and failing to continue UST maintenance therapy. Over the next month her MCD did not improve with systemic steroids or topical tacrolimus. She was given intravenous cyclosporine (CsA) which required dose reductions due to side effects. After roughly one month of CsA, she transitioned to oral tacrolimus. Although her lesions showed some improvement, they had not healed. Tacrolimus was discontinued shortly due to side effects. She was started on weekly methotrexate injections and a loading dose of UST. Approximately one month after receiving UST her wounds had nearly healed. She was discharged one month later at which point her MCD remained in near remission (Figure 1). Discussion: MCD is a rare manifestation of CD with few validated treatment options. Based on evidence from case reports, some authors have proposed an approach that escalates from topical therapies to systemic steroids, metronidazole, and then immunomodulators or TNF inhibitors; however, no treatment has shown consistent efficacy. A few case reports have shown UST to be a novel therapy for refractory MCD. We believe our case provides further evidence supporting UST as a treatment of MCD. Future prospective studies are necessary to evaluate the effectiveness of UST in treating MCD.Figure 1.: Ustekinumab successfully treats Metastatic Crohn’s disease ulcerating inflammatory lesions. (A) Gluteal cleft lesion and (B) perineal lesion upon readmission. (C) Gluteal cleft lesion and (D) perineal lesion prior to UST infusion. (E) Gluteal cleft lesion and (F) perineal lesion 2 months after UST induction infusion." @default.
• W3210133344 created "2021-11-08" @default.
• W3210133344 creator A5013639104 @default.
• W3210133344 creator A5056339603 @default.
• W3210133344 creator A5087788844 @default.
• W3210133344 creator A5090547120 @default.
• W3210133344 date "2021-10-01" @default.
• W3210133344 modified "2023-09-27" @default.
• W3210133344 title "S2447 Let’s Get You Comfortable in Your Own Skin: Response of Metastatic Crohn’s Disease to Ustekinumab" @default.
• W3210133344 doi "https://doi.org/10.14309/01.ajg.0000783320.87362.d0" @default.
• W3210133344 hasPublicationYear "2021" @default.
• W3210133344 type Work @default.
• W3210133344 sameAs 3210133344 @default.
• W3210133344 citedByCount "1" @default.
• W3210133344 countsByYear W32101333442021 @default.
• W3210133344 crossrefType "journal-article" @default.
• W3210133344 hasAuthorship W3210133344A5013639104 @default.
• W3210133344 hasAuthorship W3210133344A5056339603 @default.
• W3210133344 hasAuthorship W3210133344A5087788844 @default.
• W3210133344 hasAuthorship W3210133344A5090547120 @default.
• W3210133344 hasBestOaLocation W32101333441 @default.
• W3210133344 hasConcept C126322002 @default.
• W3210133344 hasConcept C141071460 @default.
• W3210133344 hasConcept C16005928 @default.
• W3210133344 hasConcept C2775934546 @default.
• W3210133344 hasConcept C2776760755 @default.
• W3210133344 hasConcept C2777138892 @default.
• W3210133344 hasConcept C2778720950 @default.
• W3210133344 hasConcept C2778975655 @default.
• W3210133344 hasConcept C2779134260 @default.
• W3210133344 hasConcept C2779280984 @default.
• W3210133344 hasConcept C2780132546 @default.
• W3210133344 hasConcept C2780520777 @default.
• W3210133344 hasConcept C2780941987 @default.
• W3210133344 hasConcept C2909675724 @default.
• W3210133344 hasConcept C2911091166 @default.
• W3210133344 hasConcept C71924100 @default.
• W3210133344 hasConcept C90924648 @default.
• W3210133344 hasConceptScore W3210133344C126322002 @default.
• W3210133344 hasConceptScore W3210133344C141071460 @default.
• W3210133344 hasConceptScore W3210133344C16005928 @default.
• W3210133344 hasConceptScore W3210133344C2775934546 @default.
• W3210133344 hasConceptScore W3210133344C2776760755 @default.
• W3210133344 hasConceptScore W3210133344C2777138892 @default.
• W3210133344 hasConceptScore W3210133344C2778720950 @default.
• W3210133344 hasConceptScore W3210133344C2778975655 @default.
• W3210133344 hasConceptScore W3210133344C2779134260 @default.
• W3210133344 hasConceptScore W3210133344C2779280984 @default.
• W3210133344 hasConceptScore W3210133344C2780132546 @default.
• W3210133344 hasConceptScore W3210133344C2780520777 @default.
• W3210133344 hasConceptScore W3210133344C2780941987 @default.
• W3210133344 hasConceptScore W3210133344C2909675724 @default.
• W3210133344 hasConceptScore W3210133344C2911091166 @default.
• W3210133344 hasConceptScore W3210133344C71924100 @default.
• W3210133344 hasConceptScore W3210133344C90924648 @default.
• W3210133344 hasIssue "1" @default.
• W3210133344 hasLocation W32101333441 @default.
• W3210133344 hasLocation W32101333442 @default.
• W3210133344 hasOpenAccess W3210133344 @default.
• W3210133344 hasPrimaryLocation W32101333441 @default.
• W3210133344 hasRelatedWork W1984782029 @default.
• W3210133344 hasRelatedWork W2087926731 @default.
• W3210133344 hasRelatedWork W2914662974 @default.
• W3210133344 hasRelatedWork W2960758672 @default.
• W3210133344 hasRelatedWork W3000377527 @default.
• W3210133344 hasRelatedWork W3132743342 @default.
• W3210133344 hasRelatedWork W3207621403 @default.
• W3210133344 hasRelatedWork W4244688495 @default.
• W3210133344 hasRelatedWork W4255520715 @default.
• W3210133344 hasRelatedWork W4383421022 @default.
• W3210133344 hasVolume "116" @default.
• W3210133344 isParatext "false" @default.
• W3210133344 isRetracted "false" @default.
• W3210133344 magId "3210133344" @default.
• W3210133344 workType "article" @default.